Interestingly, a decreased ratio of Ptau181/NFL was able to distinguish FTLD from Alzheimer’s disease, likely as a result of non-Aβ driven (and therefore not involving P-tau181) neuronal damage (Janelidze et al., 2020). This evidence concerns the gene NEFL and Alzheimer disease.